Edition:
United States

DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

44.78USD
20 Oct 2017
Change (% chg)

$-0.20 (-0.44%)
Prev Close
$44.98
Open
$45.10
Day's High
$45.51
Day's Low
$44.46
Volume
918,124
Avg. Vol
1,739,213
52-wk High
$88.80
52-wk Low
$42.62

Latest Key Developments (Source: Significant Developments)

‍Janus Henderson reports 10.2 pct passive stake in Dexcom
Wednesday, 11 Oct 2017 06:08am EDT 

Oct 11 (Reuters) - ‍Janus Henderson Group PLC:‍Janus Henderson Group PLC reports a 10.2 percent passive stake in Dexcom Inc as of sept 30 - SEC filing​.  Full Article

Dexcom Q2 revenue $170.6 mln; names new CFO
Tuesday, 1 Aug 2017 04:01pm EDT 

Aug 1 (Reuters) - Dexcom Inc :Dexcom reports second quarter 2017 financial results.Q2 non-GAAP loss per share $0.16.Q2 GAAP earnings per share $0.03.Q2 revenue $170.6 million versus I/B/E/S view $166.3 million.Q2 earnings per share view $-0.22 -- Thomson Reuters I/B/E/S.Dexcom announced that Quentin Blackford has been appointed chief financial officer, expected to occur on September 1, 2017.  Full Article

Dexcom announces FDA approval of G5 mobile app for android devices
Wednesday, 7 Jun 2017 08:00am EDT 

June 7 (Reuters) - Dexcom Inc :Dexcom announces fda approval of g5 mobile app for android devices.Dexcom Inc - ‍food and drug administration (fda) approval of dexcom g5 mobile app for android devices​.  Full Article

Dexcom prices offering of $350 mln of 0.75% convertible senior notes
Monday, 8 May 2017 08:04pm EDT 

May 8 (Reuters) - Dexcom Inc :Prices offering of $350 million of 0.75% convertible senior notes.Pricing of its offering of $350 million aggregate principal amount of 0.75% convertible senior notes due 2022.Notes will be senior, unsecured obligations of dexcom, and will bear interest at a rate of 0.75% per year, payable semi-annually in arrears.  Full Article

Dexcom announces proposed offering of convertible senior notes
Monday, 8 May 2017 07:09am EDT 

May 8 (Reuters) - Dexcom Inc :Dexcom announces proposed offering of $300 million of convertible senior notes.Intends to offer $300 million aggregate principal amount of convertible senior notes due 2022.Notes will be senior, unsecured obligations of Dexcom, and interest will be payable semi-annually in arrears.Notes will mature on May 15, 2022.Expects to use net proceeds of offering of notes to repay $75 million of borrowings under its existing credit facility.  Full Article

Dexcom reports Q1 revenue $142.3 million
Tuesday, 2 May 2017 04:01pm EDT 

May 2 (Reuters) - Dexcom Inc :Dexcom, Inc. Reports first quarter 2017 financial results.Q1 GAAP loss per share $0.49.Q1 revenue $142.3 million versus I/B/E/S view $144.4 million.Q1 earnings per share view $-0.50 -- Thomson Reuters I/B/E/S.  Full Article

Dexcom Inc says committed to borrow $75 mln in principal amount under its existing $200 mln revolving credit facility - SEC filing
Monday, 6 Mar 2017 09:20am EST 

Dexcom Inc : Dexcom Inc - on February 28, 2017, co committed to borrow $75 million in principal amount under its existing $200 million revolving credit facility - SEC filing . Dexcom Inc - borrowed funds were received by Dexcom on March 3, 2017 .Dexcom Inc - term of borrowing is six months and total interest anticipated on borrowing during that period is approximately $1.2 million.  Full Article

Dexcom Q4 gaap loss per share $0.09
Tuesday, 28 Feb 2017 04:01pm EST 

Dexcom Inc : Dexcom, inc. Reports fourth quarter and fiscal year 2016 financial results . Q4 gaap loss per share $0.09 . Q4 revenue $171.2 million versus i/b/e/s view $168 million .Q4 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.  Full Article

Dexcom says chief financial officer to resign, effective as of April 1
Tuesday, 21 Feb 2017 09:12am EST 

Dexcom Inc : Dexcom Inc- on Feb 14 Jess Roper, chief financial officer notified Dexcom of his decision to resign, effective as of April 1, 2017 - sec filing .Dexcom Inc - upon Roper's resignation, Dexcom will appoint Kevin Sun, as interim chief financial officer.  Full Article

Baillie Gifford & Co reports 7.25% passive stake in Dexcom Inc as of Dec 31, 2016
Friday, 20 Jan 2017 10:49am EST 

Baillie Gifford & Co:Reports 7.25 percent passive stake in Dexcom Inc as of 31 December 2016 - SEC filing.  Full Article

BRIEF-‍Janus Henderson reports 10.2 pct passive stake in Dexcom

* ‍Janus Henderson Group PLC reports a 10.2 percent passive stake in Dexcom Inc as of sept 30 - SEC filing​ Source text: (http://bit.ly/2ybb4kH) Further company coverage: